PoliticalClaims.au

### Government Spending on Private Companies

The core factual claim about substantial spending on private companies is **verified**.

According to analysis by the Australian Financial Review, private companies contracted by the federal government to administer the COVID-19 vaccine rollout received more than $200 million in payments [1].

The article's original source (The Conversation) documents multiple significant contracts: - Accenture received at least $7.8 million for software development to track and monitor vaccine doses [2] - McKinsey received a $3 million contract for a two-month engagement on vaccine strategy [3] - EY received $557,000 for influenza evaluation and COVID vaccine system readiness review [4] - A later McKinsey contract was worth $1 million for vaccine system readiness assessment and manufacturing advice [5] - DHL and Linfox were contracted for vaccine distribution and logistics (contract value undisclosed, but the 2021-22 federal budget allocated $234 million for vaccine distribution, cold storage and consumables) [6] - Four companies (Aspen Medical, Healthcare Australia, Sonic Healthcare and International SOS) held contracts totalling $155.9 million to deliver vaccination services in aged care and disability facilities [7] This substantiates the "hundreds of millions" claim, though the full figure appears distributed across multiple categories: consultancy advice, data systems, distribution logistics, and actual vaccination delivery services.

### Alternatives to Private Contractors

The claim correctly identifies existing government pharmaceutical distribution infrastructure.

Australia maintains an established pharmaceutical supply network funded under the Community Pharmacy Agreement, providing $200 million annually to pharmaceutical wholesalers with decades of experience [8].

This network routinely delivers to remote areas and is used annually for flu vaccine distribution [9].

State hospital systems also have established capabilities for delivering time-sensitive medical items including blood products and radioisotopes [10].

The claim that this existing system was bypassed is **verified** by primary sources.

Pharmaceutical wholesalers explicitly offered their expertise, but "the government did not approach them to undertake this work" [11].

The Conversation's analysis notes the decision to contract DHL and Linfox "shocked many in the pharmaceutical supply industry" [12].

### Liberal Party Donors

The claim that "many of these chosen companies are Liberal party donors" is **partially verified** with specific evidence but limited scope.

The most documented case involves Sonic Healthcare, which was awarded a multimillion-dollar contract to deliver vaccine injections to vulnerable Australians and has been "one of the biggest health sector donors to the Liberal Party in the past decade" [13].

This connection is documented by both The Sydney Morning Herald and Michael West Media.

The Conversation's article notes that firms involved are "significant Liberal Party donors" [14], but specific documented cases beyond Sonic Healthcare are limited in the sources reviewed.

The broader context shows the Pharmacy Guild donated $30,000 to the Liberal Party in October 2023 and $27,500 to the National Party in April 2024 [15], though this is general political engagement rather than specific quid pro quo tied to vaccine contracts.

### Contract Secrecy

The claim that "details of the contracts are kept secret" is **verified**.

The health department explicitly declined to release contract details, citing "commercial-in-confidence" issues [16].

The Conversation and other sources document widespread opacity about contract values, terms, and performance requirements.

The article specifically states: "We have no way of knowing what advice the government has received and indeed, whether that advice was implemented.

For-profit companies have been contracted to perform vital services, but we do not know at what cost to taxpayers and whether key performance indicators are being met — or even if they exist" [17].

Parliamentary records show concerns were raised about contract secrecy at the time [18], and the Australian National Audit Office (ANAO) conducted a performance audit finding the rollout was "partly effective" but that planning was "slow and incomplete in the early stages" [19].